This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

Mobile version RSS Subscribe Unsubscribe Archive Media Kit

Jan. 10, 2012

NAMCP AAMCN AAIHDS CME/CEU JMCM Contact Us

Targeting critical pathways
We are improving cancer treatment by developing monoclonal antibodies that target cancer stem cells.

Online CME/CEU Programs

Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management

Click Here to view the Journal of Managed Care Medicine

Managed Healthcare News

Click Here to visit the Population Health Management Institute

Collaborating reduces costs of healthcare
Kaiser Health News via USA Today Share
A small but growing number of voluntary healthcare partnerships are tackling the problems of unsatisfactory quality and rising health costs. Programs are underway across the United States, from Hillsboro, Ore., to Atlantic City, N.J. Physicians and hospitals share cost savings with employers and insurers, and in some cases, share losses if savings targets aren't met. More

'Chimera' monkeys created in stem cell study
The Guardian Share
The world's first monkeys to be created from the embryos of several individuals have been born. Scientists at the Oregon National Primate Research Center produced the animals, known as chimeras, by sticking together between three and six rhesus monkey embryos in the early stages of their development. Three animals were born at the laboratory, an individual and twins, and were said to be healthy, with no apparent birth defects following the controversial technique. More

FDA: New Treatments & Technology

Experimental herpes vaccine disappoints in study
CBS News Share
An experimental herpes vaccine failed to protect young women from the disease in a new study, dashing hopes a vaccine may soon be available to help prevent the disease. In a study of 8,300 women ages 18 to 30, the vaccine partially protected against HSV-1, the strain which typically causes cold sores but can also cause genital herpes. The vaccine, however, did not protect against HSV-2, the strain that most commonly causes genital herpes. More

Approval of HIV drug for children said promising
UPI Share
U.S. Food and Drug Administration approval of the use of an anti-retroviral drug offers a new weapon to treat HIV infection in children, researchers say. In a clinical trial studying the safety and efficacy of the drug raltegravir in HIV-infected children and adolescents, all 96 patients had previously been treated with a regimen of other HIV medications. After being treated for 24 weeks with raltegravir, 53 percent of the patients had an undetectable amount of HIV in their blood. More

Oncology

Click Here to visit the Oncology Institute

Prostate cancer screening shows no benefit
The New York Times (blog)    Share
Updated findings from one of the largest studies of prostate cancer screening show that the commonly used prostate-specific antigen blood test did not save lives, although questions remain about whether younger men or those at very high risk for the disease might benefit. In the past, the United States Preventive Services Task Force concluded healthy men should no longer be routinely screened for prostate cancer using the PSA blood test. More

Report: US cancer rates continue falling
Reuters    Share
Cancer death rates are continuing to fall, dropping by 1.8 percent per year in men and 1.6 percent per year in women between 2004 and 2008, according to the American Cancer Society's annual report on cancer statistics. Advances in cancer screening and treatment have prevented more than a million total deaths from cancer since the early 1990s, according to the report. More

Novel hepatitis C vaccine shows some early promise
HealthDay via USA Today    Share
A vaccine to protect against the hepatitis C virus, which can cause severe liver damage and even liver cancer, might be possible — but it's likely years away, researchers say. There is currently no vaccine for hepatitis C, which afflicts an estimated 170 million people worldwide. Preliminary research by British and Italian scientists suggests that the virus might one day be beatable due to a novel approach. More

Prevention & Wellness

Click Here to visit the Center for Preventive Health and Lifestyle Medicine

Some girls wrongly think HPV vaccine prevents other STDs
Los Angeles Times via Baltimore Sun Share
Some girls may be more likely to overestimate the protection they receive from the HPV vaccine, new research shows. Human papillomaviris, the most common sexually transmitted infection, can infect men and women, cause genital warts and raise the risk of cervical cancer. The study, published by the Archives of Pediatrics and Adolescent Medicine, looked at the perception of HPV risk among a population of 339 girls between age 13 and 21. More

Vaccines partially protect monkeys from HIV-like virus
Boston Globe Share
A team led by a Boston scientist announced that a vaccine had for the first time partially protected rhesus monkeys against infection with an aggressive and virulent HIV-like virus. The study is paving the way for a trial to test a similar vaccine in people. The study also provides insight into how vaccines trigger different immune responses when they are preventing infection, or helping keep an infection under control. More

Genomics and Biotech

Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute

Scientists discover the deafness gene
AOL Share
Scientists have identified a single gene that they think could be linked to age-related deafness. Hearing loss affects half of people over the age of 60 and this discovery could eventually lead to a treatment for this type of deafness. Researchers at Washington University School of Medicine found that when the FGF20 gene was taken out in mice, they appeared otherwise healthy — but couldn't hear at all. More

Disappointing results 1 year into diabetes stem cell trial
BioNews Share
Maryland biotech company Osiris Therapeutics has released an optimistic update on its Phase II trial evaluating the use of adult stem cells for treating type 1 diabetes, despite lacking positive results. The treatment, Prochymal — a formulation of adult mesenchymal stem cells — which Osiris hopes could be used in patients with newly diagnosed type 1 diabetes. The treatment failed to achieve the goal of slowing disease progression after one year. More

Behavioral Health

Click Here to visit the Behavioral Health Institute

Shortage of Adderall for ADHD sparks nationwide concern
International Business Times Share
A shortage of Adderall, used to treat Attention Deficit Disorder, is likely to continue through 2012, raising concerns among U.S. patient groups and healthcare professionals, according to a New York Times report. Multiple drug manufacturers are struggling to cater to high demand from millions of Americans who rely on drugs like Adderall and Ritalin. More

MRI scans show brain changes in kids with schizophrenia
HealthDay via USA Today Share
Children who are diagnosed with schizophrenia or a number of other psychoses go on to experience a progressively greater than normal loss of gray matter in the frontal lobe region of the brain, new research suggests. The adolescents also experience an above-average spike in the amount of so-called "cerebrospinal fluid" found in the same location, according to a report published in the Archives of General Psychiatry. More

FAST FACTS
"An estimated 1.2 million people in the United States are living with HIV, according the Centers for Disease Control and Prevention."

Managed Care eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685
Contribute news

This edition of the Managed Care eNews was sent to keads@namcp.org. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063